Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib

Front Pharmacol. 2023 Sep 5:14:1281416. doi: 10.3389/fphar.2023.1281416. eCollection 2023.

Mohamed E Shaker¹, Hesham A M Gomaa¹, Sara H Hazem², Mohamed A Abdelgawad³, Mohamed El-Mesery^{4

5}, Ahmed A Shaaban^{2

6}

¹ Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
³ Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al-Jawf, Saudi Arabia.
⁴ Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
⁵ Division of Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany.
⁶ Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1212771.].

Keywords: DAMPs; acetaminophen; alpelisib; hepatotoxicity; phosphatidylinositol 3-kinase.